维普中文期刊产品整合服务
147篇 您的检索式:作者名="Castagnetti"
    题名 作者 年代 出处 被引量
1Overexpansion technique inburn scar management显示文摘Di MD Castagnetti F Mazzeo F 2006Burns2006,32,4:1
2The Influence of Milk k-Cn and β-Lg Phenotype on Fatty Acid Composition of Milk from Reggiana Cows显示文摘MELIA S LOSI G CASTAGNETTI G B 2009Dairy Science Technology2009,89,1:1
3Anterior abrasion of earcartilage with dermablader显示文摘Di cio D Castagnetti F Baldassarre S 2003Aesthet Plast Surg2003,27,6:1
4Chro- nic myeloid leukemia (CML) patients with ' suboptimal' re- sponse to imatinib (IM) according to european leukemia net cri- teria have a poorer outcome with respect to 'optimal' responders: a GIMEMA CML WORKING PARTY analysis显示文摘CASTAGNETTI F GUGLIOTTA G PALANDRI F 2009Blood2009,114,:1
5Tubed flap interpolation in reconstruction of helical and ear lobe defects显示文摘Di Mascio D Castagnetti F 2004Dermatol Surg2004,30,41:1
6Chronic myeloid leukemia (CML) patients with 'suboptimal” response to imatinib (IM) according to European LeukemiaNet criteria have a poorer outcome with respect to 'optimal” responders:a GIMEMA CML working party analysis显示文摘Castagnetti F Gugliotta G Palandri F 2009{H}Blood2009,,22:1
7Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate:GIMEMA CML working party analysis显示文摘Castagnetti F Testoni N Luatti S 2010J Clin Oncol2010,28,16:1
8Venous blood lactate evaluation in equine neonatal intensive care显示文摘C. Castagnetti A. Pirrone J. Mariella G. Mari 2010Theriogenology2010,,3:1
9Two-stage repair in hypospadias 显示文摘Haxhirexha KN Castagnetti M Rigamonti W 2008Indian J Urol2008,24,:1
10Results of a mechanical Duhamd pull- through for the treatment of Hirschsprung's disease and intestinal neuronal dysplasia显示文摘Mattioli G Castagnetti M Martucciello G 2004Pediatr Surg2004,39,9:1
11Insulin like growth fac- tor I:could it be a marker of prematurity in the foal显示文摘Panzani S Castagnetti C Prandi A 2013Theriog enology2013,79,3:1
12The long-term dura- bility of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up 显示文摘Palandri F Castagnetti F Alimena G 2009Haematologica2009,94,2:1
13Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party显示文摘Gugliotta G Castagnetti F Palandri F 2011Blood2011,117,21:1
14The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase 显示文摘Palandri F Castagnetti F Iacobucci I 2010Haematologiea2010,95,14:1
15The domain of admissible orientation concept: A new method for five-axis tool path optimization显示文摘CASTAGNETTI C DUC E RAY P 2008Computer-Aided Design2008,40,9:1
16Results of a mechanical Duhamel pull - through for the treatment of Hir- schsprung's disease and intestinal neuronal, dysplasia显示文摘Mattioli G Castagnetti M Martucciello G 2004J Pediatr Surg2004,39,9:1
17Dasatinib and nilotinib in imatinib-resistant Philadelphia-positive chronic myelogenous leu- kemia: a 'head-to-head eomparison'显示文摘Rosti G Castagnetti F Gugliotta G 2010Leuk Lymphoma2010,51,4:1
18Nilotinib for the frontline treatment of Ph (+) chronic myeloid leukemia显示文摘Rosti G Palandri F Castagnetti F 2009Blood2009,114,24:1
19Minimally invasive management of bile leaks after blunt liver trauma in children 显示文摘Castagnetti M Houben C Patel S 2006J Pediatr Surg2006,41,9:1
20Tubed flap interpolation in recon- struction of helical and ear lobe defects 显示文摘Di Mascio D Castagnetti F 2004Dermatol Surg2004,30,4:1
返回顶部 每页显示:
共8页 首页 上一页 第1页 下一页 末页 /8 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费